Table 2 Crude incidence rates of chronic kidney disease, Canadian Observational Cohort 2000–2012
Characteristic | Chronic kidney Disease events | Total Person-years | Incidence rate per 1000 Person-years (95% CI) |
|---|---|---|---|
Overall | 150 | 10,903.4 | 13.8 (11.7, 16.1) |
Sex | |||
 Male | 115 | 9130.4 | 12.6 (10.5, 15.1) |
 Female | 35 | 1773.0 | 19.7 (14.2, 27.5) |
Ethnicity | |||
 African/Caribbean | 15 | 1806.6 | 8.3 (5.0, 13.7) |
 Non-African/Caribbean | 97 | 5742.7 | 16.9 (13.8, 20.6) |
 Unknown | 38 | 3354.0 | 11.3 (8.2, 15.6) |
Hepatitis C Co-Infection | |||
 Yes | 56 | 2156.0 | 26.0 (20.0, 33.8) |
 No | 89 | 8297.3 | 10.7 (8.7, 13.2) |
 Unknown | 5 | 450.2 | 11.1 (4.6, 26.7) |
HIV Risk Factor | |||
 Injection drug use | 45 | 1709.7 | 25.1 (18.8, 33.7) |
 Non-injection drug use | 89 | 7640.4 | 11.6 (9.5, 14.3) |
 Unknown | 16 | 1472.3 | 10.9 (6.7, 17.7) |
Age at cART initiation, years | |||
 18–39 | 43 | 5342.6 | 8.0 (6.0, 10.9) |
 40–49 | 41 | 3874.6 | 10.6 (7.8, 14.4) |
 50–59 | 40 | 1369.5 | 29.2 (21.4, 39.8) |
  ≥ 60 | 26 | 316.7 | 82.1 (55.9, 120.6) |
Baseline eGFR, mL/min/1.73m2 | |||
  > 110 | 25 | 3906.9 | 6.4 (4.3, 9.5) |
  > 90 & ≤ 110 | 41 | 4405.5 | 9.3 (6.9, 12.6) |
  ≤ 90 | 84 | 2591.0 | 32.4 (26.2, 40.2) |
Year of Follow-up | |||
 2000–2003 | 14 | 966.4 | 14.5 (8.6, 24.5) |
 2004–2008 | 58 | 4324.0 | 13.4 (10.4, 17.3) |
 2009–2012 | 78 | 5613.0 | 13.9 (11.1, 17.3) |